These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38799441)

  • 21. Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.
    Hashimoto T; Ishii N; Ohata C; Furumura M
    J Pathol; 2012 Sep; 228(1):1-7. PubMed ID: 22692770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermolysis bullosa acquisita.
    Gupta R; Woodley DT; Chen M
    Clin Dermatol; 2012; 30(1):60-9. PubMed ID: 22137228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita.
    Tukaj S; Hellberg L; Ueck C; Hänsel M; Samavedam U; Zillikens D; Ludwig RJ; Laskay T; Kasperkiewicz M
    Exp Dermatol; 2015 Jun; 24(6):471-3. PubMed ID: 25739426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune mechanism-targeted treatment of experimental epidermolysis bullosa acquisita.
    Ludwig R
    Expert Rev Clin Immunol; 2015; 11(12):1365-78. PubMed ID: 26471717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases.
    Ghorbanalipoor S; Emtenani S; Parker M; Kamaguchi M; Osterloh C; Pigors M; Gross N; Khil'chenko S; Kasprick A; Patzelt S; Wortmann D; Ibrahim IO; Izumi K; Goletz S; Boch K; Kalies K; Bieber K; Smith P; Schmidt E; Ludwig RJ
    Front Immunol; 2022; 13():865241. PubMed ID: 36248903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules.
    Sadeghi H; Lockmann A; Hund AC; Samavedam UK; Pipi E; Vafia K; Hauenschild E; Kalies K; Pas HH; Jonkman MF; Iwata H; Recke A; Schön MP; Zillikens D; Schmidt E; Ludwig RJ
    J Immunol; 2015 Apr; 194(8):3656-63. PubMed ID: 25795756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita.
    Ito Y; Kasai H; Yoshida T; Saleh MA; Amagai M; Yamagami J
    J Dermatol; 2013 Nov; 40(11):864-8. PubMed ID: 24127822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological Relevance of Anti-Hsp70 IgG Autoantibodies in Epidermolysis Bullosa Acquisita.
    Tukaj S; Mantej J; Sitko K; Zillikens D; Ludwig RJ; Bieber K; Kasperkiewicz M
    Front Immunol; 2022; 13():877958. PubMed ID: 35514963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita.
    Ludwig RJ; Recke A; Bieber K; Müller S; Marques Ade C; Banczyk D; Hirose M; Kasperkiewicz M; Ishii N; Schmidt E; Westermann J; Zillikens D; Ibrahim SM
    J Invest Dermatol; 2011 Jan; 131(1):167-76. PubMed ID: 20720563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-type lectin receptor expression is a hallmark of neutrophils infiltrating the skin in epidermolysis bullosa acquisita.
    Guerrero-Juarez CF; Schilf P; Li J; Zappia MP; Bao L; Patel PM; Gieseler-Tillmann J; Murthy S; Cole C; Sverdlov M; Frolov MV; Hashimoto T; Ishii N; Rülicke T; Bieber K; Ludwig RJ; Sadik CD; Amber KT
    Front Immunol; 2023; 14():1266359. PubMed ID: 37799716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial epidermolysis bullosa acquisita.
    Noe MH; Chen M; Woodley DT; Fairley JA
    Dermatol Online J; 2008 Dec; 14(12):2. PubMed ID: 19265615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice.
    Mihai S; Hirose M; Wang Y; Thurman JM; Holers VM; Morgan BP; Köhl J; Zillikens D; Ludwig RJ; Nimmerjahn F
    Front Immunol; 2018; 9():535. PubMed ID: 29616034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermolysis bullosa acquisita.
    Kim JH; Kim SC
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1204-13. PubMed ID: 23368767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolite analysis distinguishes between mice with epidermolysis bullosa acquisita and healthy mice.
    Schönig S; Recke A; Hirose M; Ludwig RJ; Seeger K
    Orphanet J Rare Dis; 2013 Jun; 8():93. PubMed ID: 23800341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra induction.
    Samavedam UK; Kalies K; Scheller J; Sadeghi H; Gupta Y; Jonkman MF; Schmidt E; Westermann J; Zillikens D; Rose-John S; Ludwig RJ
    J Autoimmun; 2013 Feb; 40():74-85. PubMed ID: 22980031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of quantitative trait loci in experimental epidermolysis bullosa acquisita.
    Ludwig RJ; Müller S; Marques Ad; Recke A; Schmidt E; Zillikens D; Möller S; Ibrahim SM
    J Invest Dermatol; 2012 May; 132(5):1409-15. PubMed ID: 22297639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features and diagnosis of epidermolysis bullosa acquisita.
    Vorobyev A; Ludwig RJ; Schmidt E
    Expert Rev Clin Immunol; 2017 Feb; 13(2):157-169. PubMed ID: 27580464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Glucose Metabolism Abrogates the Effector Phase of Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita.
    Schilf P; Schmitz M; Derenda-Hell A; Thieme M; Bremer T; Vaeth M; Zillikens D; Sadik CD
    J Invest Dermatol; 2021 Jul; 141(7):1646-1655.e3. PubMed ID: 33609554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for a contributory role of a xenogeneic immune response in experimental epidermolysis bullosa acquisita.
    Niebuhr M; Kasperkiewicz M; Maass S; Hauenschild E; Bieber K; Ludwig RJ; Westermann J; Kalies K
    Exp Dermatol; 2017 Dec; 26(12):1207-1213. PubMed ID: 28887841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita.
    Remington J; Chen M; Burnett J; Woodley DT
    Curr Dir Autoimmun; 2008; 10():195-205. PubMed ID: 18460887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.